|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-3-14
|
|
pubmed:abstractText |
The expression of epidermal growth factor receptor (EGFR) is one of the indicators, which can predict the malignant potential of squamous cell carcinoma of the head and neck (HNSCC). On the other hand, previous histological studies have proved tumor-associated tissue eosinophilia (TATE) to be a favorable prognostic indicator for HNSCC. We studied the prognostic significance of co-expression of EGFR and TATE.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0385-8146
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
175-81
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11893453-Adolescent,
pubmed-meshheading:11893453-Adult,
pubmed-meshheading:11893453-Aged,
pubmed-meshheading:11893453-Aged, 80 and over,
pubmed-meshheading:11893453-Carcinoma, Squamous Cell,
pubmed-meshheading:11893453-Eosinophilia,
pubmed-meshheading:11893453-Female,
pubmed-meshheading:11893453-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:11893453-Humans,
pubmed-meshheading:11893453-Male,
pubmed-meshheading:11893453-Middle Aged,
pubmed-meshheading:11893453-Nasopharyngeal Neoplasms,
pubmed-meshheading:11893453-Neoplasm Staging,
pubmed-meshheading:11893453-Predictive Value of Tests,
pubmed-meshheading:11893453-Prognosis,
pubmed-meshheading:11893453-Receptor, Epidermal Growth Factor,
pubmed-meshheading:11893453-Retrospective Studies,
pubmed-meshheading:11893453-Risk Factors,
pubmed-meshheading:11893453-Tumor Markers, Biological
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma.
|
|
pubmed:affiliation |
Department of Otolaryngology, School of Medicine, Keio University, 35 Shinanomachi Shinjuku-ku, 160-8582, Tokyo, Japan. mfujii@mc.med.keio.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
